Related by context. All words. (Click for frequent words.) 77 IMA# 75 Sym# 75 Archexin 74 CCX# 74 oral prodrug 74 EOquin TM 74 HuMax EGFr 74 Traficet EN 74 ENMD # 74 JAK inhibitor 74 Onalta 74 Bezielle 74 YONDELIS 74 liposomal formulation 73 alvespimycin 73 R#/MEM # 73 OHR/AVR# 73 TG# [003] 73 PEG SN# 73 GAMMAGARD 73 NP2 Enkephalin 73 FOLOTYN ® 73 MGd 73 tanespimycin 73 favorable pharmacokinetic profile 73 thymalfasin 73 XmAb# 73 oral ridaforolimus 73 MAGE A3 ASCI 73 HuLuc# 72 elotuzumab 72 PSMA ADC 72 Amrubicin 72 indibulin 72 INCB# [001] 72 targeted radiotherapeutic 72 BrachySil TM 72 Nanobody 72 Aplidin 72 enzastaurin 72 mertansine 72 AeroLEF TM 72 radiation sensitizer 72 AEG# 72 Amplimexon 72 Xanafide 72 ZOLINZA 72 Solazed 72 CR# vcMMAE 71 phase IIb clinical 71 Zolinza 71 phase IIa clinical 71 HGS ETR2 71 Tarvacin TM 71 riociguat 71 PXD# 71 LHRH antagonists 71 Alocrest 71 custirsen 71 TPI ASM8 71 CBLC# 71 investigational monoclonal antibody 71 Carfilzomib 71 Symadex 71 vidofludimus 71 BrachySil 71 romidepsin 71 PRX# 71 ALN TTR 71 Trofex 71 Tyrima 71 Neuradiab 71 SNT MC# 71 OncoVEX GM CSF 71 investigational humanized monoclonal antibody 71 Vicinium TM 71 AP# [003] 71 EOquin 71 Onconase 71 IL# PE#QQR 71 CEQ# 71 oral deforolimus 71 GAP #B# 71 obatoclax 71 ELACYT 70 HQK 70 BAY #-# 70 ospemifene 70 HGS ETR1 70 metaglidasen 70 CIMZIA ™ 70 deforolimus 70 ganetespib 70 CINQUIL 70 INT# [002] 70 Aurexis 70 ATL# [001] 70 CINTREDEKIN BESUDOTOX 70 MYDICAR ® 70 UPLYSO 70 ularitide 70 Chemophase 70 Virulizin ® 70 Phase #b/#a clinical 70 Vandetanib 70 LEP ETU 70 CTAP# Capsules 70 pan HDAC inhibitor 70 DXL# 70 Proxinium TM 70 atacicept 70 lomitapide 70 OncoVEX 70 BRAF inhibitor 70 Pimavanserin 70 OncoGel 70 HGS# 70 MGCD# [001] 70 CoFactor 70 anticancer compound 70 ACAPODENE 70 vorinostat 70 therapeutic monoclonal antibody 70 bevacizumab Avastin ® 70 ganaxolone 70 Azedra ™ 70 HuMax CD4 70 Panzem R NCD 70 preclinical efficacy 70 L BLP# 70 CD3 monoclonal antibody 70 AZILECT ® 70 Marqibo 70 Solazed TM 70 huC# DM4 70 Alpharadin 70 Dapagliflozin 70 ALN TTR# 70 Exherin TM 70 histone deacetylase HDAC inhibitor 70 pertuzumab 70 CYT# potent vascular disrupting 70 GRN#L 70 ALN PCS 70 Phase Ib study 70 MyVax R 70 OMP #M# 70 delafloxacin 69 CD# monoclonal antibody 69 blinatumomab 69 Revimmune 69 ARIKACE ™ 69 MEK inhibitors 69 Panzem 69 ON #.Na 69 galiximab 69 elacytarabine 69 Tarvacin 69 CCR9 antagonist 69 Phase Ib clinical 69 PRT# 69 HER2 positive metastatic breast 69 preclinically 69 phase IIb trial 69 ProSavin 69 forodesine 69 zanolimumab 69 ALN VSP 69 IRX 2 69 HCV protease inhibitor 69 teriflunomide 69 GRNVAC1 69 Squalamine 69 AQ4N 69 rNAPc2 69 TLK# 69 KNS # 69 PolyActive ® 69 Marqibo TM 69 Aviptadil 69 depsipeptide 69 APOPTONE 69 pharmacokinetic PK 69 velafermin belinostat 69 TREANDA 69 Evoltra ® 69 tubulin inhibitor 69 Exelixis compounds 69 Myocet 69 QuadraSphere 69 docetaxel Taxotere ® 69 EndoTAG TM -1 69 erlotinib Tarceva ® 69 trastuzumab DM1 T DM1 69 oral FTY# 69 DAVANAT 69 Pertuzumab 69 solithromycin 69 cannabinor 69 Fodosine 69 VitiGam 69 Clolar ® 69 Litx 69 miRview ™ squamous 69 Elagolix 69 ARIKACE 69 PLK1 SNALP 69 Sapacitabine 69 novel VDA molecule 69 JAK inhibitors 69 mapatumumab 69 PI3K/Akt pathway inhibitor 69 CA4P 69 CD# antibody [001] 69 PRTX 69 Vidofludimus 69 Telatinib 69 histone deacetylase inhibitor 69 reslizumab 69 TELCYTA 69 rALLy clinical trial 69 torezolid phosphate 69 GRN# 69 synthetic retinoid 69 hematological cancers 69 Onco TCS 69 LEUKINE 69 TACI Ig 69 RGB # 69 vascular disrupting agent 69 PLX cells 68 Neulasta ® 68 octreotide implant 68 Xcellerated T Cells 68 belinostat 68 Panzem R 68 MEK inhibitor RDEA# 68 bafetinib 68 Nanobody ® 68 miRview mets 68 corticosteroid dexamethasone 68 teduglutide 68 TRO# 68 proteasome inhibitor 68 monoclonal antibody conjugated 68 rBChE 68 rxRNA 68 ruxolitinib 68 subcutaneous formulation 68 docetaxel Taxotere R 68 Gliadel Wafer 68 Cerashield 68 #I TM# 68 cancer immunotherapies 68 p# biomarker 68 PDE4 inhibitor 68 Dacogen injection 68 refractory chronic lymphocytic 68 fosbretabulin 68 registrational 68 MOZOBIL 68 CLORETAZINE TM VNP#M 68 DermaVir Patch 68 crizotinib PF # 68 liposomal doxorubicin 68 Stedivaze 68 eniluracil 68 sorafenib tablets 68 ApoB SNALP 68 OvaRex ® MAb 68 varespladib 68 Aliskiren 68 CIMZIA TM 68 oral gallium 68 cediranib 68 Degarelix 68 LY# [003] 68 TRV# [001] 68 entinostat 68 ataluren 68 tafamidis 68 pomalidomide 68 Ceflatonin 68 JAK2 inhibitor 68 nonclinical studies 68 Blinatumomab 68 methylnaltrexone 68 dacetuzumab 68 Generx 68 Imprime PGG 68 diabetic neuropathic pain 68 PROMACTA 68 EFAPROXYN 68 Quinamed 68 pharmacodynamic effects 68 trastuzumab Herceptin 68 nanopharmaceutical 68 R#/MEM 68 Aclidinium 68 pediatric acute lymphoblastic 68 Phase Ib II 68 tezampanel 68 Ophena TM 68 vascular disrupting agents 68 lapatinib Tykerb 68 huN# DM1 68 evaluating tivozanib 68 NXL# 68 INCB# [003] 68 Poly ICLC 68 Darinaparsin 68 ocular formulation 68 investigational therapies 68 malignant ascites 68 Liprostin 68 ISTODAX 68 Mipomersen 68 OvaRex R 68 axitinib 68 Cotara 68 Guanilib 68 vivo potency 68 RLY# 68 protein kinase inhibitor 68 Pralatrexate 68 Phase 2a trial 68 EndoTAG TM 68 Perifosine 68 BRIM2 68 trastuzumab emtansine T DM1 68 ATL/TV# 68 Targretin 68 anticancer agent 68 Azedra TM 68 omega interferon 68 eprotirome 68 Catena ® 68 SIR Spheres 68 Seliciclib 68 PrevOnco 68 targeting CD# 68 Annamycin 68 antitumor activity 68 novel peptide 68 Campath ® 68 MabCampath 68 CXB# 68 Phase 1b trial 68 busulfan 68 Ophena 68 CRLX# 68 DP b# 68 neratinib 68 PROCHYMAL 68 myelofibrosis polycythemia vera 68 davunetide intranasal AL 68 angiogenesis inhibitor 68 Tamibarotene 68 PNT# 68 #D#C# 68 lintuzumab 68 selective androgen receptor modulator 68 novel histone deacetylase 68 Allovectin 7 68 OXi# 68 proteasome inhibitor bortezomib 68 Onalta ™ 68 ZK EPO 68 Afatinib 68 Phase IIIb clinical 68 Trastuzumab 68 immunotherapeutic agent 67 Bendavia 67 Irinotecan 67 regorafenib 67 BiTE 67 Insegia 67 Genasense ® oblimersen 67 KRN# 67 PHX# 67 PS# [001] 67 Soliris eculizumab 67 Civacir 67 Prodarsan ® 67 HuMax CD# 67 Nexavar ® 67 Angiolix 67 Spiegelmer ® 67 Orazol 67 Relivar 67 SERMs 67 lucinactant 67 Aplidin R 67 THALOMID 67 MORAb 67 Triolex 67 IMiDs 67 trial evaluating PRX# 67 orally bioavailable 67 Tesetaxel 67 HCD# [002] 67 Tavocept 67 Tanespimycin 67 MAA submission 67 EndoTAG 67 refractory gout 67 IAP inhibitors 67 Allovectin 7 R 67 relapsed multiple myeloma 67 Dasatinib 67 Toraymyxin TM 67 farletuzumab 67 ISIS # 67 Cloretazine R VNP#M 67 ADAGIO study 67 Golimumab 67 DOS# 67 Omacetaxine 67 cilengitide 67 talactoferrin 67 Pyridorin 67 Increlex ® 67 VA# [002] 67 ThermoDox R 67 PKC# 67 DOR# 67 hA# 67 tiapamil 67 bortezomib Velcade 67 standard chemotherapy regimen 67 OMNARIS HFA 67 Thiarabine 67 Icatibant 67 receptor tyrosine kinase inhibitor 67 Cloretazine ® 67 eculizumab 67 peptibody 67 Firazyr 67 sunitinib malate 67 oral antiviral 67 Aflibercept 67 bicifadine 67 lumiliximab 67 HGS ETR1 mapatumumab 67 Cloretazine 67 PROSTVAC TM 67 pharmacodynamic PD 67 Arikace 67 ADVEXIN 67 Zorbtive TM 67 RIGScan CR 67 iSONEP 67 RAPAFLO 67 humanized antibody 67 plasma kallikrein inhibitor 67 BNC# 67 Zoraxel 67 glufosfamide 67 ASONEP 67 HepaSphere 67 acyclovir Lauriad R 67 Daclizumab 67 Solazed ™ 67 ATL# [002] 67 ThermoDox ® 67 HDAC Inhibitor 67 BZL# 67 Phase 1a clinical 67 RNAi therapeutic targeting 67 radiolabeled 67 pharmacodynamic properties 67 radiotherapeutic 67 Clonicel 67 SEPET TM 67 MAP# 67 HspE7 67 systemically administered 67 Temsirolimus 67 IAP inhibitor 67 Vidaza azacitidine 67 Romidepsin 67 ToGA 67 active moiety 67 AzaSite Plus 67 Removab 67 EDEMA3 67 Corgentin 67 metastatic neuroendocrine tumors 67 radezolid 67 MKC# MKC# PP 67 Curaxin 67 Methylnaltrexone 67 PEP# [003] 67 cutaneous T cell 67 azacytidine 67 adecatumumab 67 Tarceva TM 67 DACH platinum 67 Cetrorelix 67 oral taxane 67 Altastaph 67 CANCIDAS 67 PrevOnco ™ 67 JAK2 inhibitors 67 Safinamide 67 GSK# [001] 67 PCK# 67 vosaroxin 67 Proellex TM 67 ELND# 67 Pemetrexed 67 Dacogen decitabine 67 calcineurin inhibitors 67 humanized anti 67 tesmilifene 67 SARMs 67 DPX Survivac 67 efficacy tolerability 67 MAb 67 ZACTIMA 67 IMC #B 67 MDV# 67 non metastatic osteosarcoma 67 HIF PH inhibitors 67 Pivotal Phase III 67 AGHD 67 generation purine nucleoside 67 drug ISA# 67 ThermoDox 67 Deforolimus 67 BAL# [002] 67 Genentech Rituxan 67 MEK inhibitor 67 CDK inhibitor 67 bortezomib Velcade ® 67 luteinizing hormone releasing 67 relapsed MM 67 NeuroSTAT ® 67 registrational trial 67 candidate CRLX# 67 MNTX 67 Phase IIb III 67 leading oral taxane 67 Prostate AdenoCarcinoma Treatment 67 Anticalins 67 ponatinib 67 antiangiogenic agents 67 Tezampanel 67 PEG Interferon lambda 66 vemurafenib 66 Preclinical studies suggest 66 Chrysalin 66 Oral NKTR 66 Liposomal 66 EP #R 66 otelixizumab 66 hormone agonist 66 KL4 surfactant 66 Epanova 66 candidate TNFerade biologic 66 thalidomide Thalomid 66 Prodarsan R 66 iobenguane 66 NNR Therapeutics 66 Zysolin TM 66 imetelstat 66 Granisetron 66 Cethrin R 66 Vidaza ® 66 ixabepilone 66 VAPRISOL 66 afatinib 66 HCV protease inhibitors 66 PREOS R 66 sulodexide 66 Resten NG 66 Azixa 66 LymphoStat B belimumab 66 orally administered inhibitor 66 Survivin antagonist 66 rFIXFc 66 Raptiva ® 66 Tracleer R 66 pitavastatin 66 myeloproliferative diseases 66 JVRS 66 Radilex 66 Epratuzumab 66 SNALP technology 66 Lisofylline LSF 66 ZADAXIN ® 66 recurrent glioma 66 Curaxin CBLC# 66 Cervista HPV HR 66 Excellarate 66 LUVENIQ 66 THR beta agonist 66 TOLAMBA 66 Vidaza R 66 eltrombopag 66 catheter occlusion 66 tolerability pharmacokinetics 66 BRIM3 66 pharmacodynamic profiles 66 ONCONASE 66 PEGylated interferon 66 herpetic keratitis 66 JAK1 66 Asentar 66 oral picoplatin 66 CORT # 66 Bicifadine 66 placebo controlled Phase 66 oncolytic vaccine 66 flavopiridol 66 NEUGENE 66 eTag assays 66 anti EGFR antibody 66 pralatrexate 66 Enzastaurin 66 immatics 66 LNPs 66 Saforis 66 IMC A# 66 CYT# 66 Microplasmin 66 tesetaxel 66 amrubicin 66 ONCONASE R 66 Apoptone 66 Loramyc R 66 RECOTHROM R 66 Leukine ® 66 PARP inhibitor 66 opioid induced bowel dysfunction 66 hormone LHRH antagonist 66 Dalbavancin 66 CA9 SCAN 66 Zerenex 66 targeted antifolate 66 multi kinase inhibitor 66 BLA submission 66 TH# [003] 66 TELINTRA 66 afamelanotide 66 bardoxolone 66 GAMMAGARD LIQUID 66 PDX pralatrexate 66 cetuximab Erbitux R 66 Personalized Immunotherapy 66 interferon gamma 1b 66 Angiocept 66 NEUMUNE 66 radiolabeled TM# 66 diarrhea predominant irritable 66 modulator SERM 66 Phenoptin 66 ALGRX 66 intranasal delivery 66 hyperphenylalaninemia HPA due 66 VEGF Trap 66 Virulizin R 66 thetreatment 66 tolevamer 66 menadione 66 Adnectin 66 BEXXAR 66 Phase #/#a trial 66 BioNumerik 66 TRISENOX ® 66 cetuximab Erbitux ® 66 PSN# [002] 66 gefitinib Iressa 66 Phase IIa clinical 66 OPAXIO 66 Androxal TM 66 Hepatocellular Carcinoma HCC 66 NexACT ® 66 superficial bladder cancer 66 myeloproliferative disorders 66 antiangiogenic activity 66 Fludara ® 66 paclitaxel Taxol ® 66 tamibarotene 66 DCVax ® 66 PROVENGE sipuleucel T 66 orally bioavailable mimics 66 non nucleoside 66 Phase #b/#a 66 proteasome inhibitors 66 CD# CEA 66 cleavable linker 66 Onrigin 66 trastuzumab DM1 66 Alvesco R 66 Cannabinor 66 pegfilgrastim 66 RhuDex ® 66 pseudobulbar affect PBA 66 Panitumumab 66 TORISEL 66 acetonide FA 66 induced macular edema 66 atrasentan 66 HSP# inhibitor 66 ESBA# 66 dose escalation Phase 66 TAFA# 66 mecamylamine 66 OMP #R# 66 alefacept 66 IMGN# 66 trabectedin 66 Veronate 66 AEGR 66 velafermin 66 Troxatyl 66 AKT inhibitor 66 PNP inhibitor 66 nucleotide analog 66 pain palliation 66 rALLy 66 Rigel R# 66 Huntexil 66 Injectable Suspension 66 BiTE antibody 66 Diabetic Macular Edema 66 multicenter Phase II 66 cMET 66 SAR# [002] 66 anti CD# antibodies 66 systemic RNAi therapeutic 66 antitumor efficacy 66 NGX# 66 rilonacept 66 BMS# 66 Anthim 66 vascular disrupting 66 prostone 66 immunological diseases 66 MYCAMINE 66 Bortezomib 66 SUTENT ® 66 ALN HPN 66 ORENCIA R 66 Mitoxantrone 66 CYC# 66 Onalta TM 66 APTIVUS 66 Cardio Vascu Grow 66 PSN# [001] 66 TNF Tumor Necrosis Factor 66 inhibitor RG# 66 LymphoStat B TM 66 Elocalcitol 66 Belinostat 66 cobiprostone 66 DNA intercalator 66 deferiprone 66 Zenvia ™ 66 ZEVALIN ® 66 TriRima 66 SAR# [004] 66 sorafenib Nexavar 66 Lixivaptan 66 delipidation 66 ProLindac 66 S/GSK# 66 Fibrillex TM 66 volociximab 66 ZYBRESTAT 66 aerosolized KL4 surfactant 66 Romiplostim 66 ONTAK 66 REMINYL ® 66 DCVax R 66 humanized monoclonal antibody 66 GW# [003] 66 ongoing Phase 1b 66 NPC 1C 66 Ceflatonin ® 66 intranasal formulation 66 efaproxiral 66 Urocidin TM 66 MGN# 66 XL# XL# 66 ostarine 66 histamine dihydrochloride 66 investigational pan BCR 65 C1 INH 65 Granulocyte Colony Stimulating Factor 65 apoptosis inducer 65 anti amnesic 65 YONDELIS R 65 DXL TM 65 Hycamtin 65 INC# 65 Oncaspar 65 kidney urologic 65 Vaprisol 65 Phase III Pivotal 65 azacitidine 65 tiuxetan 65 Hemopurifier ® 65 favorable tolerability 65 TheraCIM 65 PhG alpha 1 65 anticancer therapies 65 Metastatic Melanoma 65 Atiprimod 65 mitogen activated ERK kinase 65 Voreloxin 65 AVONEX ® 65 Rasagiline 65 PREOS 65 Radezolid 65 inhibit metastasis 65 pradefovir 65 Bafetinib 65 immunotherapeutic vaccine 65 CERVARIX 65 #ME# 65 ZADAXIN 65 Kahalalide F 65 humanized monoclonal 65 Intravenous CP 65 Ixempra 65 Pazopanib 65 Cleviprex TM clevidipine 65 MyVax ® 65 Cimzia ® certolizumab pegol 65 paclitaxel poliglumex 65 CD# expressing 65 Phase IIa trials 65 topically applied SEPA 65 ASPIRE HIGHER 65 isoform selective 65 Vascugel 65 NeuVax 65 REOLYSIN ® 65 Davanat 65 Factor VIIa 65 sodium thiosulfate STS 65 Zalypsis 65 Allovectin 7 ® 65 INTEGRILIN 65 Vorinostat 65 molecular biomarkers 65 XYOTAX TM 65 masitinib 65 stable nucleic acid 65 triphendiol 65 GED aPC 65 pharmacokinetic profile 65 NTDDS 65 Hsp# inhibitor 65 dexpramipexole 65 MultiStem 65 SANVAR 65 TBC# 65 Capesaris 65 Pirfenidone 65 MVA BN R 65 anti CD3 65 TOCOSOL Paclitaxel 65 Gleevec resistant 65 peritumoral brain edema 65 Spheramine 65 direct thrombin inhibitors 65 RAV# 65 TYZEKA 65 DU #b 65 Cand5 65 therapeutic peptide 65 Fleximer 65 dirucotide 65 oncolytic virus therapies 65 Actimmune ® 65 liprotamase 65 iniparib 65 Zemiva ™ 65 PGL# 65 placebo controlled clinical 65 FavId 65 Anavex #-# 65 IV Busulfex 65 TMC# [002] 65 ANYARA 65 anticancer activity 65 Phase 1b clinical trials 65 Nimotuzumab 65 Elesclomol 65 cariprazine 65 dosage regimens 65 Cx# [002] 65 demonstrated antitumor activity 65 NPM1 65 Stimuvax R 65 Trofex TM 65 Ataluren 65 Zybrestat 65 Phase IIB 65 AzaSite Xtra 65 clevidipine 65 Advexin 65 CGEN # 65 tramiprosate 65 flurpiridaz F 65 Ampligen ® 65 GEM OS2 65 Phase IIa trial 65 anticancer therapy 65 Valortim 65 Natalizumab 65 inhaled iloprost 65 dasatinib Sprycel 65 Alfimeprase 65 TKM ApoB 65 Cethrin 65 ACZ# 65 Evoltra 65 pharmacokinetic PK profile 65 Gemzar ® 65 mGluR2 NAM 65 Microspheres 65 GVAX Pancreas Vaccine 65 DAVANAT R 65 telomerase therapeutic 65 Aurora kinase 65 Navelbine ® 65 biodistribution 65 Spiegelmers R 65 TroVax 65 NEUGENE antisense 65 sipuleucel T 65 OncoVex 65 biodegradable implant 65 angiographic outcomes 65 Etoposide 65 LymphoStat B 65 trodusquemine 65 uricase 65 ATIR 65 MAXY G# 65 Gefitinib 65 TYSABRI natalizumab 65 brivaracetam 65 pharmacodynamic profile 65 retaspimycin 65 GALNS 65 effector function 65 Aerosurf 65 ROTARIX 65 Restanza 65 chemotherapy induced neutropenia 65 sargramostim 65 trastuzumab Herceptin ® 65 Stanate R 65 IMiDs ® 65 CRMD# 65 mu opioid receptor antagonist 65 pharmacodynamic parameters 65 Myolimus 65 Anturol TM 65 Zarnestra 65 Epigenomics proprietary 65 Zingo TM 65 molecularly targeted 65 BXT # 65 cintredekin besudotox 65 BEMA TM Fentanyl 65 Palifosfamide 65 noninfectious uveitis 65 bevacizumab Avastin 65 Mepact 65 Azacitidine 65 interferon lambda 65 vandetanib 65 relapsed refractory multiple myeloma 65 Cloretazine R 65 cytostatic 65 Plicera 65 StemEx 65 ofatumumab HuMax CD# 65 IgG1 antibody 65 LibiGel ® 65 patented Bioral 65 Velcade bortezomib 65 Locteron ® 65 Apaziquone 65 ATIR TM 65 mTOR inhibition 65 AVE# 65 Genz # 65 CB2 selective receptor agonist 65 selective orally bioavailable 65 nalbuphine ER 65 topical formulation 65 RoACTEMRA